These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15361189)

  • 1. Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma.
    Raspollini MR; Amunni G; Villanucci A; Baroni G; Boddi V; Taddei GL
    Int J Gynecol Cancer; 2004; 14(5):815-23. PubMed ID: 15361189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates.
    Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
    Oncol Rep; 2004 Feb; 11(2):309-13. PubMed ID: 14719060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian serous carcinoma: relationship of p53 and bcl-2 with tumor angiogenesis and VEGF expression.
    Crasta JA; Mishra S; Vallikad E
    Int J Gynecol Pathol; 2011 Nov; 30(6):521-6. PubMed ID: 21979585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer.
    Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K
    Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas.
    Hartenbach EM; Olson TA; Goswitz JJ; Mohanraj D; Twiggs LB; Carson LF; Ramakrishnan S
    Cancer Lett; 1997 Dec; 121(2):169-75. PubMed ID: 9570355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of P-glycoprotein and proliferative index in advanced low grade serous ovarian carcinomas.
    Raspollini MR; Amunni G; Villanucci A; Baroni G; Boddi V; Taddei GL
    J Chemother; 2003 Aug; 15(4):380-6. PubMed ID: 12962367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF18 as a potential biomarker in serous and mucinous ovarian tumors.
    El-Gendi S; Abdelzaher E; Mostafa MF; Sheasha GA
    Tumour Biol; 2016 Mar; 37(3):3173-83. PubMed ID: 26427667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma.
    Karavasilis V; Malamou-Mitsi V; Briasoulis E; Tsanou E; Kitsou E; Pavlidis N
    Int J Gynecol Cancer; 2006; 16 Suppl 1():241-6. PubMed ID: 16515598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of microvessel density and angiogenesis-related molecules in epithelial ovarian cancer].
    Tan XJ; Lang JH; Lou WZ; Shen K; Xu XY
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):274-8. PubMed ID: 18788631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: correlation with vascular endothelial growth factor, microvessel density, and clinical outcome.
    Shi L; Chen XM; Wang L; Zhang L; Chen Z
    Cancer; 2007 Apr; 109(8):1523-31. PubMed ID: 17342767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
    Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
    J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction.
    Semaan A; Munkarah AR; Arabi H; Bandyopadhyay S; Seward S; Kumar S; Qazi A; Hussein Y; Morris RT; Ali-Fehmi R
    Gynecol Oncol; 2011 Apr; 121(1):181-6. PubMed ID: 21167567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
    Fine BA; Valente PT; Feinstein GI; Dey T
    Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome.
    Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
    Gynecol Oncol; 2004 Mar; 92(3):806-12. PubMed ID: 14984945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of vascular endothelial growth factor expression and microvessel density in carcinoma of ampulla of Vater.
    Chen L; Tao SF; Zheng YX
    Hepatogastroenterology; 2006; 53(67):45-50. PubMed ID: 16506374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of tumor angiogenesis in epithelial ovarian cancer: in association with transforming growth factor beta and vascular endothelial growth factor.
    Sönmezer M; Güngör M; Ensari A; Ortaç F
    Int J Gynecol Cancer; 2004; 14(1):82-8. PubMed ID: 14764033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor expression in early stage ovarian carcinoma.
    Paley PJ; Staskus KA; Gebhard K; Mohanraj D; Twiggs LB; Carson LF; Ramakrishnan S
    Cancer; 1997 Jul; 80(1):98-106. PubMed ID: 9210714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor angiogenesis in advanced stage ovarian carcinoma.
    Hollingsworth HC; Kohn EC; Steinberg SM; Rothenberg ML; Merino MJ
    Am J Pathol; 1995 Jul; 147(1):33-41. PubMed ID: 7541612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of epidermal growth factor receptor expression with tumor microdensity vessels and with vascular endothelial growth factor expression in ovarian carcinoma.
    Raspollini MR; Castiglione F; Garbini F; Villanucci A; Amunni G; Baroni G; Boddi V; Taddei GL
    Int J Surg Pathol; 2005 Apr; 13(2):135-42. PubMed ID: 15864375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.
    Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR
    Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.